General
Preferred name
DL-Laudanosine
Synonyms
Laudanosine (R,S) ()
LAUDANOSINE ()
DL-Laudanosine ()
P&D ID
PD045768
CAS
1699-51-0
Tags
available
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
DL-Laudanosine, an Atracurium and Cisatracurium metabolite, crosses the blood¨Cbrain barrier and may cause excitement and seizure activity[1].
PRICE
49
DESCRIPTION
DL-Laudanosine acts as a small conductance Ca2+-activated K+ channel blocker, it is also an agonist of Neuronal acetylcholine receptors.
(Enamine Bioactive Compounds)
DESCRIPTION
DL-Laudanosine (Laudanosine) is a recognized metabolite of atracurium and cisatracurium.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
1
Organisms
0
Compound Sets
3
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
21
Molecular Weight
357.19
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
0
Rotatable Bonds
6
Ring Count
3
Aromatic Ring Count
2
cLogP
3.49
TPSA
40.16
Fraction CSP3
0.43
Chiral centers
1.0
Largest ring
6.0
QED
0.79
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Target
Drug Metabolite
Pathway
Metabolism
Metabolic Enzyme/Protease
Source data
